Recent Insider Trading: Endonovo Therapeutics, Inc. $ENDV

face-1370955_1920

Endonovo Therapeutics, Inc. (ENDV) insider have most recently took part in a trading activity. On Sep 15, 2017 Mann Michael Scott, President, 10% Owner bought 35,000 shares having total worth of $1,050 at the price of $0.03 per share, following the transaction a total of 23,486,189 shares owned by Mann Michael Scott. Before this latest buy, Mann Michael Scott purchased ENDV at 114 other times during the past twelve months, for a total investment of $20.96M at an average of $0.1 per share.

The stock has experienced a total of 37 insider trades in the past three months. These trades include 37 buy trades. Furthermore, over the past 12 months , the stock was traded 114 times by insiders. an employee of the company was the buyer in 114 instances.

Time Frame Number of Insider Buy Number of Insider Sell Stock Price Change(%)
3 Month 37 0 -57.81%
12 Month 114 0 -96.25%

Shares of Endonovo Therapeutics, Inc. (ENDV) traded up 3.85% on Sep 18, 2017, hitting $0.03. 1,115,294 shares of the company’s stock traded hands. Endonovo Therapeutics, Inc. has a 52 week low of $0.01 and a 52 week high of $0.72. The company’s market cap is $0 million.

Hanover Portfolio Acquisitions Inc is comprised of two business segments: a debt portfolio management company and an intellectual property management and commercialization company. Debt portfolio management segment purchases defaulted, unsecured, consumer receivables in the secondary market and generates revenue through collections utilizing an outsourced collection network and through the strategic resale of portfolios. This segment acquires credit-card receivable portfolios at significant discounts to the total amounts owed by the debtors. Intellectual property management and commercialization segment is operated through the company’s wholly-owned subsidiary, IP Resources International, Inc. (IPR). IPR focuses on licensing various commercially desirable technologies and patents from companies that need operating capital or that need help commercializing their technology and sublicense such technology in designated territories.

William White

William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.

About the Author

William White
William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.